Dog Healthcare Market Overview
The Dog Healthcare Market is expected to register a growth rate of approximately 5.6% during the forecast period, 2018-2023. The dog healthcare market addresses a variety of health conditions related to dogs, ranging from cancer, diabetes, and rabies, to dental plaque and hair loss. The market is primarily driven by increasing dog adoption, growing prevalence of several canine diseases, and rise in canine health awareness. North America, followed by Europe, is expected to dominate the market, while Asia-Pacific is expected to exhibit the fastest growth rate, owing to factors such as rise in awareness about canine health and ongoing biomedical as well as technological advances regarding the treatment of various canine diseases.
Increase in Dog Adoption Propels the Dog Healthcare Market
Rise in the adoption of dogs as companions to human beings is expected to propel market growth, owing to the direct association of pet population with the need for proper dog healthcare products and services. According to ASPCA (American Society for the Prevention of Cruelty to Animals), every year, around 6.5 million companion animals enter animal shelters, in the United States. Out of those animals, approximately 3.3 million are dogs. It is also estimated that 3.2 million shelter animals are adopted as pets, each year. Among this, 1.6 million are dogs. 68% of US households, or about 85 million families, own a pet, according to the 2017-2018 National Pet Owners Survey conducted by the American Pet Products Association (APPA). The survey also reveals that the total US expenditure on pets was approximately USD 69,400 million, in 2017.
In addition to the aforementioned factor, the growing prevalence of several canine diseases and the rise in canine health awareness are expected to propel the growth of the market over the forecast period.
Side Effects Associated With Products and Treatments Limit the Growth of the Dog Healthcare Market
The side effects associated with the drugs and other methods of treatment used for various conditions associated with canine health are expected to restrain market growth. For example, glucosamine and chondroitin are two significant components of cartilage, which are naturally produced inside the body, and most joint supplements contain these two components. These can cause adverse reactions in dogs, such as diarrhea, vomiting, and change in blood glucose levels. According to the American Kennel Club, the commonly used joint supplements containing glucosamine are often expected to have side effects, such as allergies (specifically among those who are allergic to shellfish), fatigue, insomnia, excessive thirst, and urination (at high doses). In addition, since it is a sugar-based substance, it may also cause diabetes in dogs. NSAIDs (non-steroidal anti-inflammatory drugs) could reduce blood flow to the kidneys, thus causing kidney damage, sometimes even leading to kidney failure. As a result of these mild or severe side effects caused by the drugs and devices used for treating dogs, the reluctance of pet owners to put their pet animals under medication is expected to restrain the dog healthcare market, thus impeding market growth.
North America to Dominate the Dog Healthcare Market
North America is expected to dominate the dog healthcare market over the forecast period, owing to increasing dog adoption, increasing per capita animal healthcare expenditure, and a rise in prevalence of many diverse canine diseases. For example, The American Animal Hospital Association (AAHA) estimated 40-50% of dogs to be overweight, and 25% dogs to be obese, in 2017. In 2016, the Association for Pet Obesity Prevention (APOP) classified 54% of dogs as overweight or obese in the United States.
In addition, , growing awareness about canine health among pet owners, helpful initiatives by the government, good infrastructure, and rise in product innovation, such as new vaccine launches and competitive pricing, are some other factors propelling the growth of the dog healthcare market in North America.
North America is expected to be followed by Europe, as the second largest market for dog healthcare, while Asia-Pacific is expected to demonstrate the highest growth rate, owing to the high incidence of vitamin deficiency, metabolic disorders, bacterial infection, gout in dogs, and the increase in awareness about various health issues associated with the canine population. Hence, the aforementioned factors are expected to fuel the growth of the dog healthcare market in Asia-Pacific.
Key Developments in the Dog Healthcare Market
- Jun 2018 – Elanco Animal Health announced the US Food and Drug Administration (FDA) approval of Credelio (Lotilaner), an oral drug to treat and provide protection against ticks and fleas.
- Jul 2018 – CBD DOG Health announced the launch of new products containing healing cannabinoids, which could be used to treat joint pain.
Major Players: Adam Equipment, Bayer AG, Boehringer Ingelheim, Ceva, Elanco, Intervet, Mars Inc., Medtronic, Virbac, Zoetis among others.
The present era is observing a transformation in the dog healthcare market, owing to the increasing fondness of companion animals, along with the rise in awareness regarding their health condition. Hence, companies are determined to provide treatment and medication that can cure prevalent animal diseases and have the potential to serve the dog healthcare market.
Dog Healthcare Market
2018 – 2023
Largest Market Share by Region
Adam Equipment, Bayer AG, Boehringer Ingelheim, Ceva, Elanco, Intervet, Mars Inc., Medtronic, Virbac, Zoetis among others
The Dog Healthcare Market offers the latest trends, growth prospects, industry competitiveness, major players, value/supply chain, regional market share, and forecast up to 2023.
Reasons to Purchase the Report
- Current and future outlook for the Dog Healthcare Market in developed and emerging markets
- Analysis of various perspectives of the market, with the help of Porter’s five forces analysis
- The segment that is expected to dominate the market
- Regions that are expected to witness the fastest growth during the forecast period
- Identification of the latest developments, market shares, and strategies employed by the major market players
- Three-month analyst support, along with the market estimate sheet (in Excel)
Customization of the Report
- This report can be customized to meet your requirements. Please contact our representative, who will ensure that you to get a report that suits your needs
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
5.3 Pipeline Analysis
5.4 Regulatory Scenario
6. Market Dynamics
6.1 Market Drivers
6.1.1 Increase in Dog Adoption
6.1.2 High Prevalence of Various Canine Diseases
6.1.3 Rise in Canine Health Awareness
6.2 Market Restraints
6.2.1 Side Effects Associated with Products and Treatments
6.2.2 High Cost of Certain Products
6.4 Key Challenges
7. Market Segmentation
7.1 By Products
220.127.116.11.5 Hormonal Drugs
18.104.22.168.6 Others (Suppliments etc.)
22.214.171.124 Grooming products
126.96.36.199.1 Skin Care products
188.8.131.52.2 Oral Care Products
184.108.40.206 Therapeutic Devices
220.127.116.11 Surgical Devices
18.104.22.168 Anesthesia Devices
22.214.171.124 Others (Scales etc.)
7.2 By Geography
7.2.1 North America
126.96.36.199 United States
188.8.131.52 United Kingdom
184.108.40.206 Rest of Europe
220.127.116.11 South Korea
18.104.22.168 Rest of Asia-Pacific
7.2.4 Middle East & Africa
22.214.171.124 South Africa
126.96.36.199 Rest of Middle East & Africa
7.2.5 South America
188.8.131.52 Rest of South America
8. Competitive Landscape
8.1 Merger & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Adam Equipment
9.2 Bayer AG
9.3 Boehringer Ingelheim
9.7 Mars, Inc.
*List Not Exhaustive
10. Future of the Market